Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Pioglitazone on Intima Media Thickness and Autonomic/Endothelial Function in Impaired Glucose Tolerance
2005-004421-26Phase 3Terminated
- Sponsor
- Institut für Gesundheits- und Praxismanagement
- Start
- Mar 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of pioglitazone in prediabetes (3 arms), sponsored by Institut für Gesundheits- und Praxismanagement. Primary endpoint: Change in intima media thickness. Started Mar 2006; status: terminated.
02
Drugs
pioglitazone
03
Conditions
prediabetes
Beyond the preview
Go deeper on 2005-004421-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004421-26.